This man? The 361st richest man in the world?
French MP and billionaire Olivier Dassault dies in helicopter crash
March 7, 2021
Holy shit! His company Medidata provided clinical trial software for Moderna's COVID vaccine trials (Phase 3).
I don't think a lot of people have picked up on this video---I'll repost and see if the evening people are more interested. I think Martin's dropping this stuff now for a reason---he's probably known this all along, since it's his job to dig out these relationships.
Very interesting! Another layer in the rabbit hole to research. I've been hearing rumblings over the past week about Trump's EO on moving forward with the Mnra's, so this part of the message is not surprising. I've always known there's a lot more to Warp Speed than meets the eye---
Just saying . . .$113 million is peanuts when the Lib govt. is adding drugs to their federal drug stash. Smallpox vaxx/treatments have been a govt. priority since 2002, with Bush worrying about Saddam Hussein' bioweapons. This seems more like a topping off of the stash.
I'm not so worried about small pox or ebola used as a bio-weapon (unless they aerosolize them). It takes physical contact with infected body fluids to spread, unlike the flu or COVID. It may be a useful tool, if they want to lock down a certain location or terrorize people with the big headlines to hog the MSM narrative for awhile.
Sounds like Barry needs more income. . .Back in 2008, he was a major stockholder in a company to process carbon exchanges in Chicago. I don't know if he ever sold the stock, but he'd make more money from this than Netflix if the Dems could push through the carbon exchanges.
Absolutely---I was thinking of those "hot lots" identified in VAERS. I believe they were super-charged formulations to see how high the dosage could go before most recipients died or had disabling injuries immediately after the jab.
I prefer using horse paste pills (for humans) and iodine gargle. The cost of Regeneron is $2100/treatment, so we're still feeding the coffers of Pharma. In addition, the data from the clinical study feeding the 81% claim is not all that impressive in absolute numbers:
The late-stage study, jointly run with the National Institute of Allergy and Infectious Diseases, enrolled people who lived in a household with someone diagnosed with Covid within the previous four days. Earlier results from the trial showed the drug cut the risk of infection by 81% within the first month. The new data shows the protection was maintained, with an 82% reduction in symptomatic infections for as long as eight months after the therapy was administered.
During the study, none of the people in the treatment group were hospitalized due to Covid, compared with six people in the placebo group. No deaths stemming from Covid infection occurred in either group.
This likely will give ammo to lawyers going up against the vaccine mandates, since it appears to be more effective than the jab. But, I fully anticipate that the EUA will be stretched out to get as many vaxxed as possible.
During the 2016 campaign, the CEO of Macy's (Terry Lundgren) claimed that Trump was raaay-cist and dropped his suit line from stores. Interesting, but he left the Macy's Board of Directors suddenly in Dec. 2017 and has only been heard of sporadically since.
Always a "sewing needle":
Weaver, AL:
https://www.wvtm13.com/article/police-needle-found-in-childs-halloween-candy/29667521
Wilson County, TN:
Albuquerque NM:
https://nypost.com/2018/11/01/girl-bit-into-halloween-candy-with-a-sewing-needle-in-it-cops/
Medidata seems to have had a significant amount of control on the design, recruitment, execution and evaluation phases of the Moderna Phase 3 clinical trial. Its software allowed for decentralizing the test sites and pulling then pulling it all together via their cloud platform. Medidata also collected reports back from the trial participants via that cute little app on their cell phones. Looks like everything (good and bad) that went on in Phase 3 had an electronic trail.
https://www.clinicaltrialsarena.com/news/medidata-support-trials-covid-19-vaccine/